Literature DB >> 17874140

Selective late steroid withdrawal after renal transplantation.

Guido F Laube1, Jutta Falger, Markus J Kemper, Andrea Zingg-Schenk, Thomas J Neuhaus.   

Abstract

Steroid withdrawal (SW) after paediatric renal transplantation (RTPL) is controversial. Selective late SW has been performed in our unit since 1995. The safety and effects of SW were analysed retrospectively in 47 patients undergoing RTPL between 1995 and 2004. Initial immunosuppression consisted of cyclosporine A, azathioprine or mycophenolate mofetil and steroids. Criteria for SW were: (1) stable renal function, (2) time interval after RTPL > or = 1 year, (3) no rejection or time interval after last rejection > or = 1 year and (4) good compliance. SW was performed in 30 patients at an age of 13.5 years (range 4.5-18.5) and 2.2 years (range 1-6.6) after RTPL. After SW, one patient experienced a steroid-sensitive rejection. Follow-up after SW (1.3 year; range 0.25-7.5) showed maintained renal function: glomerular filtration rate at SW and currently was 82 (65-128) and 82 (42-115) ml/min per 1.73 m(2), respectively. The number of patients on antihypertensive treatment did not significantly change (at SW: n = 15; currently: n = 11). Height and body mass index (BMI) remained stable: Median standard deviation score (SDS) for height/BMI at SW and currently was -1.1/0.2 and -0.8/0.1, respectively. Selective late SW was safe regarding renal function and had no significant effect on blood pressure and growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17874140     DOI: 10.1007/s00467-007-0576-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  25 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development.

Authors:  A Prader; R H Largo; L Molinari; C Issler
Journal:  Helv Paediatr Acta Suppl       Date:  1989-06

3.  Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.

Authors:  José Oberholzer; Eunice John; Adisorn Lumpaopong; Giuliano Testa; Howard N Sankary; Leslie Briars; Kerri A Kraft; Peter S Knight; Priya Verghese; Enrico Benedetti
Journal:  Pediatr Transplant       Date:  2005-08

4.  Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients.

Authors:  Douglas M Silverstein; Diego H Aviles; Pamela M LeBlanc; Flavia F Jung; V Matti Vehaskari
Journal:  Pediatr Transplant       Date:  2005-10

5.  Steroid preservation: the rationale for continued prescribing.

Authors:  Stephen D Marks; Richard S Trompeter
Journal:  Pediatr Nephrol       Date:  2005-12-31       Impact factor: 3.714

6.  Risk of steroid withdrawal in pediatric renal transplant patients with suspected steroid toxicity.

Authors:  G Klaus; N Jeck; M Konrad; B Förster; M Soergel
Journal:  Clin Nephrol       Date:  2001-12       Impact factor: 0.975

Review 7.  Corticosteroid avoidance in pediatric renal transplantation.

Authors:  Jayakumar R Vidhun; Minnie M Sarwal
Journal:  Pediatr Nephrol       Date:  2005-02-03       Impact factor: 3.714

8.  Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients.

Authors:  Mark M Mitsnefes; Philip R Khoury; Paul T McEnery
Journal:  J Pediatr       Date:  2003-07       Impact factor: 4.406

Review 9.  Hypertension and end-organ damage in pediatric renal transplantation.

Authors:  Mark M Mitsnefes
Journal:  Pediatr Transplant       Date:  2004-08

10.  Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.

Authors:  Britta Höcker; Ulrike John; Christian Plank; Elke Wühl; Lutz T Weber; Joachim Misselwitz; Wolfgang Rascher; Otto Mehls; Burkhard Tönshoff
Journal:  Transplantation       Date:  2004-07-27       Impact factor: 4.939

View more
  4 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.

Authors:  Troels K Bergmann; Katherine A Barraclough; Katie J Lee; Christine E Staatz
Journal:  Clin Pharmacokinet       Date:  2012-11       Impact factor: 6.447

2.  A study on strategies for improving growth and body composition after renal transplantation.

Authors:  Jorge R Ferraris; Titania Pasqualini; Guillermo Alonso; Susana Legal; Patricia Sorroche; Ana Galich; Paula Coccia; Lidia Ghezzi; Verónica Ferraris; Liliana Karabatas; Clara Guida; Héctor Jasper
Journal:  Pediatr Nephrol       Date:  2010-02-12       Impact factor: 3.714

3.  Outcome after renal transplantation. Part II: quality of life and psychosocial adjustment.

Authors:  Jutta Falger; Markus A Landolt; Bea Latal; Eva M Rüth; Thomas J Neuhaus; Guido F Laube
Journal:  Pediatr Nephrol       Date:  2008-04-03       Impact factor: 3.714

Review 4.  Steroid withdrawal in renal transplantation.

Authors:  Ryszard Grenda
Journal:  Pediatr Nephrol       Date:  2013-01-04       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.